On Saturday, November 29, 2025, Delta State stood still when the chairman of Goldfield Group, Dr. Abimbade Abdulyekeen ...
In his acceptance speech, Dr. Adeshina said he was humbled for the recognition bestowed on him and accepted the award of Doctor of Management Science (D.MSc) (Honoris Causa) in Entrepreneurial Finance ...
The professor will no longer be able to teach a class on diversity after she showed students a diagram that included the “Make America Great Again” slogan as an example of white supremacy. By ...
Nearly 44% of the 16,000 truck driving programs listed nationwide by the government may be forced to close if they lose their ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the ...
The B-Class Electric Drive is the first all-electric car that Mercedes-Benz has offered in the U.S. It has about 85 miles of range, and its 36-kWh lithium-ion battery can be replenished in 4 hours.
Berkshire Hathaway has delivered a 19.9% annual return from 1965 to 2025, nearly doubling the S&P 500's gains. Investors can buy Berkshire B shares without high fees, unlike hedge funds, which have ...
RECALL ALERT: There are 2 recalls on this vehicle. Learn More. There are 2 recalls on this vehicle. Learn More. RECALL ALERT: There are 2 recalls on this vehicle. Learn More. There are 2 recalls on ...
Somerset Community College announced an exciting milestone: the graduation of the first Commercial Driver’s License class at ...
Stacey Morgenstern says her Health Coach Institute does things differently. Over the past ten years, she and co-founder Carey Peters have taught ten-thousand students from 30 countries how to coach ...
Novo's Wegovy is significantly expanding the obesity treatment market, given its strong efficacy, and is poised to remain a key drug in the market until patent expiration in 2032.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results